Tower Research Capital LLC (Trc) Regeneron Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,510 shares of REGN stock, worth $3.82 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,510
Previous 947 481.84%
Holding current value
$3.82 Million
Previous $497,000 523.34%
% of portfolio
0.09%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$534.91 - $598.71 $2.44 Million - $2.73 Million
4,563 Added 481.84%
5,510 $3.1 Million
Q2 2025

Aug 14, 2025
SELL
$483.07 - $625.6 $2 Million - $2.6 Million
-4,150 Reduced 81.42%
947 $497,000
Q1 2025

May 15, 2025
SELL
$634.14 - $744.83 $2.14 Million - $2.51 Million
-3,375 Reduced 39.84%
5,097 $3.23 Million
Q4 2024

Feb 13, 2025
BUY
$701.85 - $1046.91 $3.49 Million - $5.21 Million
4,978 Added 142.47%
8,472 $6.03 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $6.49 Million - $7.62 Million
-6,337 Reduced 64.46%
3,494 $3.67 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $1.15 Million - $1.4 Million
1,307 Added 15.33%
9,831 $10.3 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $9.05 Million - $9.96 Million
-10,029 Reduced 54.06%
8,524 $8.2 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $10.4 Million - $11.8 Million
13,392 Added 259.48%
18,553 $16.3 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $4.01 Million - $4.89 Million
-5,787 Reduced 52.86%
5,161 $4.25 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $6.24 Million - $7.4 Million
8,910 Added 437.19%
10,948 $7.87 Million
Q1 2023

May 09, 2023
SELL
$680.49 - $826.97 $1.12 Million - $1.36 Million
-1,648 Reduced 44.71%
2,038 $1.68 Million
Q4 2022

Feb 10, 2023
SELL
$705.89 - $766.39 $12.1 Million - $13.2 Million
-17,163 Reduced 82.32%
3,686 $2.66 Million
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $943,606 - $1.19 Million
1,644 Added 8.56%
20,849 $14.4 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $7.28 Million - $9.81 Million
-13,274 Reduced 40.87%
19,205 $11.4 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $11 Million - $12.9 Million
18,450 Added 131.51%
32,479 $22.7 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $4.3 Million - $5.31 Million
7,909 Added 129.23%
14,029 $8.86 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $945,427 - $1.12 Million
1,647 Added 36.82%
6,120 $3.7 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $5.4 Million - $6.37 Million
-11,412 Reduced 71.84%
4,473 $2.5 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $5.58 Million - $6.85 Million
12,498 Added 369.0%
15,885 $7.52 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $706,927 - $898,594
-1,478 Reduced 30.38%
3,387 $1.64 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $181,401 - $219,183
333 Added 7.35%
4,865 $2.72 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $2.24 Million - $2.92 Million
4,532 New
4,532 $2.83 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $608,821 - $895,412
-1,811 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$274.13 - $376.51 $87,995 - $120,859
321 Added 21.54%
1,811 $680,000
Q3 2019

Nov 05, 2019
SELL
$273.46 - $318.39 $916,090 - $1.07 Million
-3,350 Reduced 69.21%
1,490 $413,000
Q2 2019

Aug 13, 2019
BUY
$299.6 - $414.82 $875,431 - $1.21 Million
2,922 Added 152.35%
4,840 $1.52 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $566,677 - $669,465
1,523 Added 385.57%
1,918 $788,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $519,849 - $623,905
-1,548 Reduced 79.67%
395 $148,000
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $797,438 - $927,726
-2,271 Reduced 53.89%
1,943 $785,000
Q2 2018

Aug 15, 2018
BUY
$284.6 - $344.99 $1.2 Million - $1.45 Million
4,214 New
4,214 $1.45 Million
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $90,324 - $112,621
-286 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$358.63 - $469.95 $68,498 - $89,760
-191 Reduced 40.04%
286 $108,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $205,768 - $240,408
477
477 $213,000

Others Institutions Holding REGN

# of Institutions
1,476
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email